|
|
|
l |
Home | l | UK Companies | l | Genomics Topics | l | Species with sequenced Genomes | l | Contact |
l |
Recent Publications by Featured Genomics Companies: | ![]() | ||
| Cell Cycle Laboratory | Differences in the DNA replication of unicellular eukaryotes and metazoans: known unknowns.
Although the basic mechanisms of DNA synthesis are conserved across... | Cell Cycle Laboratory, London Research Institute, Blanche Lane, | EMBO Rep. 2010 Feb 26. DOI Direct Link |
| GlaxoSmithKline | Novel bis-phenanthridine derivatives with easily tunable linkers, study of their interactions with DNA and screening of antiproliferative activity.
Series of novel peptide-bridged bis-phenanthridine derivatives as well as... | Division of Organic Chemistry and Biochemistry, Ruder Boskovic Institute, | Eur J Med Chem. 2010 Feb 12. DOI Direct Link |
| GlaxoSmithKline | Reduced proliferation of non-megakaryocytic acute myelogenous leukemia and other leukemia and lymphoma cell lines in response to eltrombopag.
Leukemia cell lines were treated with eltrombopag or thrombopoietin and... | Oncology Translational Research, GlaxoSmithKline, 1250 South Collegeville | Leuk Res. 2010 Mar 2. DOI Direct Link |
| Merck Sharp & Dohme Research Laboratories | Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder.
INTRODUCTION: We conducted a double-blind 1-year trial of asenapine in... | Schering-Plough (formerly NV Organon), now Merck Sharp & Dohme, Oss, The | Pharmacopsychiatry. 2010 Mar 4. DOI Direct Link |
| GlaxoSmithKline | Novel bis-phenanthridine derivatives with easily tunable linkers, study of their interactions with DNA and screening of antiproliferative activity.
Series of novel peptide-bridged bis-phenanthridine derivatives as well as... | Division of Organic Chemistry and Biochemistry, Ruder Boskovic Institute, | Eur J Med Chem. 2010 Feb 12. DOI Direct Link |
| GlaxoSmithKline | Reduced proliferation of non-megakaryocytic acute myelogenous leukemia and other leukemia and lymphoma cell lines in response to eltrombopag.
Leukemia cell lines were treated with eltrombopag or thrombopoietin and... | Oncology Translational Research, GlaxoSmithKline, 1250 South Collegeville | Leuk Res. 2010 Mar 2. DOI Direct Link |
| Pfizer Global Research and Development | Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity.
Brain-penetrable proline amides were developed as 5HT2c agonists with more... | Pfizer Global Research and Development, Chemistry Department, 10770 | Bioorg Med Chem Lett. 2010 Jan 25. DOI Direct Link |
Patents: | ![]() | |
| Company | US Patent No. | Title |
| Syngenta | 7671257 | Inbred corn line G07-NPDI4214 |
| AstraZeneca | 7671195 | Process for preparing dibenzothiazepine compounds |
| AstraZeneca | 7671060 | Heteroaryl benzamide derivatives |
| AstraZeneca | 7670625 | Pharmaceutical composition containing an active ingredient and a micronised carrier/diluent |
| AstraZeneca | 7670591 | Heteroaryl substituted benzoxazoles |
| Forensic Science Service | 7668660 | Analysis of DNA |
| Syngenta | 7667108 | Inbred corn line G07-NPFA7278 |
| GlaxoSmithKline | 7666988 | BASB082 Polypeptides |
| GlaxoSmithKline | 7666988 | BASB082 Polypeptides |
| AstraZeneca | 7666892 | Metalloproteinase inhibitors |